Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
88.0%
% of BBH's 27 holdings also in IBB
9.8%
% of IBB's 261 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 11.2% | 8.6% | 8.6% |
|
AMGEN INC | 16.1% | 8.4% | 8.4% |
|
GILEAD SCIENCES INC | 12.5% | 8.2% | 8.2% |
|
REGENERON PHARMACEUTICALS | 5.2% | 7.3% | 5.2% |
|
ALNYLAM PHARMACEUTICALS INC | 4.4% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to IBB
|
AMGEN INC | 7.7% |
|
GILEAD SCIENCES INC | 4.3% |
 |
ICON PLC | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
NATERA INC | 2.5% |
 |
ARGENX SE ADR | 2.4% |
|
QIAGEN NV | 1.5% |
|
INTRA-CELLULAR THERAPIES INC | 1.4% |
|
ILLUMINA INC | 1.3% |
|
EXACT SCIENCES CORP | 1.2% |
BBH Underweight Relative to IBB
 |
METTLER-TOLEDO INTERNATIONAL | -2.6% |
|
WATERS CORP | -2.3% |
|
REGENERON PHARMACEUTICALS | -2.2% |
|
UNITED THERAPEUTICS CORP | -1.5% |
|
EXELIXIS INC | -1.1% |
 |
GENMAB A/S SPONSORED ADR | -1.0% |
|
VAXCYTE, INC. | -0.9% |
|
MEDPACE HOLDINGS, INC. | -0.9% |
|
HALOZYME THERAPEUTICS INC | -0.9% |
|
ASCENDIS PHARMA A/S | -0.7% |